Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Yes, it was a very good conference call. Management is a getting quite a bit done and very quickly. It's nice to see the stock so up. I'm holding. I see no reason to let go of my shares at this level. Big things coming.
It sure does!
"Together, PURA and KALY have signed over a $1 million agreement to produce CBD infused water for Generex Biotechnology, Inc. (OTCBB: GNBT). The GNBT product is expected to be on shelves soon."
Could be why they needed the quick deal.
Did you think I was making a case against all shorting? Shorting goes on in all stocks -- as do short squeezes. Place your bet. I've already placed mine.
If you understand how death spirals work, you also understand there are ways to mitigate them.
You mentioned the risk/reward as being the reason for financing this way, and banks not lending to them. Hello! Why do you think we refer to GNBT as 'speculative'. I think we are all in agreement on that.
The size of this deal is tiny. That's the first point in GNBT management knowing what they are doing. I also presume they have restricted or eliminated shorting. That would be another sign. None of us know this for sure at this point.
As you know, particularly due to its past, GNBT is speculative. And it is small cap and in the bio industry. Banks don't line up to lend to companies like this. Everyone knows that.
You should refrain from presuming what folks know and don't know. Not that it matters, but I am a permanently certified treasury pro. I eat, sleep and breathe this stuff. I've borrowed money from just about every bank in existence, on behalf of one company or another. I've worked for a Fortune 500 healthcare company, and I have a particular interest in the small caps. I think I'm certainty as qualified as many, perhaps more than some, to judge the financing, based upon the public information the company provides, knowing fully well we don't see all the negotiations or details.
It runs counter to everything else the company has done, including management donating its own shares back to fund acquisitions. Have you seen the documents?? Unless you have, and know the particulars, I presume management is smart enough to prevent the worst case scenario here. And at a mere $2 million, it seems to me they are.
This type of financing is pretty typical for a small cap and/or high risk company. Yes it *could* be a death spiral, if done incorrectly, but if done correctly, it could be exactly what the company needs. Not having seen the signed documents myself, I would presume management is smart enough to limit or prevent short selling. And seeing as the amount is merely $2 million, it seems they were smart enough to limit based upon typical volumes. Yes, I expected a price decline, both due to this and to being ex-div, however, if you look at the low volume, it's not that big of a deal. Very few are selling. And that's a good thing. And even on higher volume days, most of the trades are at higher dollars, then a few bring it down at the end. That's not a true decline. That's just a few folks playing around.
Yes, GNBT is speculative, but so far they seem to be delivering on their promises. It's more than worth a ticket IMO. I like the $3.50 conversion price. It means the plan is to go well beyond that.
I disagree. It is a leap and a judgement to assume GNBT is behind garbage like that write-up. I get way too many of these outlets in my junk mail doing this type of non-informative write-up on all kind of companies, pennies to large cap.
I think think this board should be for investors or those considering investment only in GNBT. If folks aren't one of those types of people, I have to wonder why they are here.
That's a terrible write-up. It doesn't say anything! It doesn't even give a price target for GNBT. Other than insider and institutional percentage holders, it doesn't much of anything at all. Seems like click bait to me.
The information is widely available. I thought it was commonly known.
Just look at the Bloomberg US spinoff index. Over the past three years the BSOI is up 60% versus 35% for the S&P 500. For the last 10 years, the spin index has returned 342% versus 154% for the market (S&P 500).
While these appears to be more like 100% better, the over all the percentage is closer to 50% when you go out longer than 10 years.
Historically, companies who do spinoffs like this do significantly better than the market over the course of the next 2-3 years -- both the parent and the spinoff. On average, they beat the market by nearly 50%.
I don't even recall what I was saying. When did the rules get so tight?
Hardly anyone saw that 1/17/19 date, or that press release. In fact, it wasn't even a 'release' -- it was just an article on information the company put out over a week ago. And that information did not include anything about the dividend. The article seems to have other typos in it, this might have been one as well. Who knows? It wasn't an official release from the company. It did not post to any stock sites. I wouldn't get too concerned about it. The only information that matters is what comes directly from the company. And AFAICT, they just decided to move up the dividend. Actually better than having to wait another month, IMO. And it probably arose due to their discussions with FINRA. Why wait if there is no need to?
Glad I bought when I did, and am holding for the long term. I see a lot of potential in this company, and they seem to be executing well for investors.
Did you see today's news release?
"The Company believes that the ex-dividend date will be Monday, January 28, 2019 by application of FINRA Uniform Practice Code rules which provide ex-dividend date for dividends of less than 25 percent of the value a company’s common stock is the second business day prior to the record date. "
It reads to me like they are treating this dividend like a regular dividend, a less than 25% dividend, not the special 25% or more type stock dividend. Sounds like if you want the dividend, you need to own the stock on January 28th.
Does anyone read this differently than I do?
Well, I took advantage of the low PPS and volume this morning and bought more. I won't be letting go of my shares for a very long time. Too many good things coming up. I believe this will be the best investment in my portfolio over the next year or two.
Low volume push down -- buy now if you have the chance. This is a gift.
I wonder if some are selling not realizing the situation with the ex-date, thinking as long as they were 'of record' yesterday they would get the dividend.
Have you seen the one and only price target -- $285.71 !!
I have no idea who the analyst is or where it came from or when. But it sure looks nice, doesn't it?!
https://money.cnn.com/quote/forecast/forecast.html?symb=GNBT
It seems I was wrong and you are correct. It's the 25% rule. I found it here. http://www.finra.org/sites/default/files/NoticeDocument/p003997.pdf
It does make sense. I wonder how high the stock price will push now it can be purchased for another month + before going ex-dividend.
What are your thoughts on that?
I think he misspoke and meant to say 'record date' rather than 'pay date'. It's a one word mistake, mistakes happen.
What is in writing is very clear, plus it is how these things ALWAYS work. Shareholders of record on that DAY - TODAY Jan 17 - receive 1 share of Nugenex for every 4 shares of GNBT owned TODAY, payable on Feb 25.
https://www.marketwatch.com/press-release/generex-announces-record-payment-dates-for-nugenerex-immuno-oncology-stock-dividend-2019-01-16
I'm sorry, but I believe you are incorrect. Spinoff shares function the same as cash dividends -- you have shareholders of record, then you have a payable date. The day after the record date is the 'ex-dividend' date.
You either own your shares today or you do not get the dividend of Nugenex shares.
https://www.investopedia.com/terms/r/recorddate.asp
Guys, just a quick and simple clarification on the spinoff of Nugenex Immuno-Oncology. Only 2 dates matter - January 17 and February 25.
The only people who get the 'dividend shares' of Nugenex are the people who own on the date of record, that is, TODAY. If you own shares at the end of the trading day today, you are entitled to the spinoff shares. Those shares will be 'delivered' on February 25 to your account. Depending upon who your broker is, and what their procedures are, it might take some extra days to actually see those shares in your account.
Does anyone know what in the Sam Hill is going on here today?!! Halted? Resumed? No news?!! Over 8 MILLION SHARES!!!
Somebody knows something, just wish it was ME!!!
LOL
Looks like tomorrow might be another good day for GBTC! Hopefully, the start of many. GLTA
It's poised to be a GREAT crypto day!
Go GBTC!
You seem to be correct, BooDog. Kind of interesting timing, eh?
It would be nice to get SYN back in business. It's been too long. What happened to the meetings with the FDA? Where are the products in the pipeline? Is everything dead without a functional CEO. The CFO can't do it all! Can't Kirk get some interim talent in, at least!? I can't imagine he wants to see his investment go down the drain here.
Hoping for the best, but not happy about how things have languished.
Anyone know what's going on here?!! 30%+ move?!! I know we're talking pennies at this point, but I'm wondering if FINALLY we'll be getting a CEO who can move these product forward.
Fingers crossed, though not yet holding my breath!
GLTAL
Looks like we've crossed. We should see some upward movement resuming any day now, possibly tomorrow. If not tomorrow, definitely early next week! Go SYN!
Thank you!
Excellent volume! Hope somebody knows something good that we only anticipate! The LTers in this deserve a nice WIN! Go SYN! (haven't had the chance to say THAT in awhile!)
It's time to resume the trajectory. We've been on hold (and decline!) for too long. The investment is a positive. No one likes or wants dilution, but everyone needs $$$ to operate. Let's hope this is the last trip to the trough though. Perhaps we can start funding operations with actual SALES of product! Just a thought. ;)
Looks like Michael Dell is behind the $12 million. No wonder we've been creeping back up. Let's get this back to where it should be. These last few months have been ridiculous.
http://companies.bizjournals.com/profile/synthetic-biologics/150155/
Easy is right -- $5-6 easy!
Based upon the 8-k (and I did read it!), and how the last secondary went, I expect we are up some 50%+ from offering price within the next couple of weeks.
The offering price of $3, though less than where the PPS had gone, was pretty darned good. Good, and yet it offered longs a discount to current value so they could load up more. There was a big block trade that went off. My guess is that is Kirk or 3rd Security (same thing, I know) pulling in more shares. Just a guess, mind you, but I'd bet I'm right.
Sure 004, 005, and 010 are big drivers, but I believe it is a mistake to ignore Trimesta. Absolutely no reason to cross the t's and dot the i's with the UCLA agreement if there was no value there. Attorney's are NOT cheap!
So, good luck to all longs! We have a winner here, that has not changed. The 8-k, for me, only confirms it. As for traders....who cares?! Sorry guys, but to me SYN is not for trading even though it falls easily into those swings. Too much $$$$$$ to be made as a long! And short term taxes kill me! :)
Hope not!! I just sold AEZS! :)
Moved the money into ISR. I think the dip is about done over there. Getting ready to rip, IMO. Still lots of volatility though, so caveat emptor, as always.
Longer term, ISR looks really really good. Very positive results. Could be a buyout candidate.
I think we just found out the reason for the insider buys!
Orphan drug status.
Nice!
Anyone watching AH? What the heck! So many manipulations with this stock lately. It is hard to believe with a quarter like this one that so many are playing games. This takedown was a concerted effort, beginning with the downgrades from Zacks and Maxim. For no real reasons! Some of the big-ish players have their paw prints all over this and are shorting the heck out of it while also accumulating for the long run. These kinds of things are where the SEC should spend their time!! In my opinion.
I have bought more so while I can complain, I am also thankful! Hanging on for the long term with this one!!!
The microbiome is where it is at! First IBS, then what's next -- diabetes? obesity? autism perhaps?? SYN-004 could be the beginning of great things to come. Tomorrow begins May. Get ready for Digestive Disease Week -- where Dr. Pimentel gets the stage! We are only 1/3 through Q2. Much to look forward to this month and next. Let's hope the government can maintain the illusion of a recovery for a little while longer!!!!! ;)
The Ya hoo board used to be GREAT...until a few shady characters showed up. Now, one of the best long time SYNers has left (DQ) and maggots have taken his place. Really ugly characters, not just the usual bashers, but just not nice people. I doubt anyone of any consequence will be going there for a long time. That place has soured. And it's a real shame. I know I used to get a lot of good information there. Now, it's just BS and bad taste. It always was more active there than here for SYN. Now, it's every wo/man for him/herself. No more sharing of good information. Looks like IHU B will have to step up. Though not too many post here to fully make up for the Ya hoo loss.
:(
Agree, the volume has been low and it has been retail.
The question is, why file a notice of late filing on a Friday, indicating a filing will probably be forthcoming on Monday, only to not put anything out on Monday? What could have possibly occurred over the weekend to delay what he thought on Friday would be out on Monday?!
It would have been better to say something like 'within the next few weeks' or put a date far out there -- then BEAT it by filing earlier than the projected date.
You know what they say about promising and delivering. Well, it's all true!
Like everyone here, I hope to see a nice jump in revenues and a solidly forming business. Fingers crossed.
Thanks, Seel. And back atcha!
It is kind of hard not to get excited about what's to come.
SYN is about to come into its own. And I cannot wait to see it!
Just think, we're in the $2s now. Not that long ago we were working hard at getting here. Even in the low $2s, we're still TWOS! We should be far, far higher, but I'm at least happy with the progress we've made.
It's only a matter of time before the next breakout. The chart seems to be setting up nicely for one, probably within the next week or two. At least, that's what I see happening! Especially when the technicals coincide with the fundamentals of the c-diff announcement!
There was a bit of a try. There was a nice block at 2.44. But overall, most of the volume came at higher prices. I think it says something that we were green a good part of the day. It tells me that the market understands the deal, that the shorts can yell about dilution, but that it is hollow. There won't be any dilution for at least a few months -- probably not until 2016. In the meantime, we will have some very positive news on C-diff, IBS, Pertussis and Trimesta. I think a little dilution to move all of these drugs forward into Phase IIIs is a fair trade! Can you imagine what our PPS will be when c-diff, IBS and pertussis are in Phase IIIs and Trimesta gets partnered?!
No wonder that research house just upgraded SYN to a BUY this quarter from a HOLD last quarter. They've looked at the pipeline, like we have!